# Mont. Code Ann. § 33-32-106: 33-32-106 Disclosure of utilization review requirements -- drug benefit information

> Montana · Statutes · In force

URL: https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-106

## Section

- **Citation:** Mont. Code Ann. § 33-32-106
- **Heading:** 33-32-106 Disclosure of utilization review requirements -- drug benefit information
- **Jurisdiction:** Montana
- **Kind:** Statutes
- **Status:** In force
- **Text as of:** August 14, 2026
- **Source:** Compiled text
- **Location:** MT Code / Title 33 / Chapter 32 / Part 1 / Section 33-32-106

## Text

33-32-106 . Disclosure of utilization review requirements -- drug benefit information. (1) A utilization review organization shall make its current utilization review plan prepared pursuant to 33-32-103 , including clinical review criteria, standards, procedures, requirements, and restrictions, readily accessible on its website to covered persons, prospective covered persons, and health care providers. The utilization review plan must be described in detail and in easily understandable language.

(2) If a utilization review organization intends to implement a new or amended utilization review plan, including any new or amended clinical review criteria, standards, procedures, requirements, or restrictions, the entity may not implement the change until it has:

(a) notified health care providers in writing of the new or amended utilization review plan, including any new or amended clinical review criteria, standards, procedures, requirements, or restrictions, no less than 60 days before the new or amended plan is to be implemented; and

(b) updated its website to reflect the new or amended utilization review plan, including any new or amended clinical review criteria, standards, procedures, requirements, or restrictions, to make the information accessible to covered persons, prospective covered persons, and health care providers.

(3) A health insurance issuer or utilization review organization, as applicable, shall display on its public website current prescription drug benefit information, including formulary lists of each prescription drug covered under the health insurance issuer's plan.

## Nearby sections

- [Mont. Code Ann. § 33-32-101 33-32-101 Purpose](https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-101.md)
- [Mont. Code Ann. § 33-32-102 33-32-102 Definitions](https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-102.md)
- [Mont. Code Ann. § 33-32-103 33-32-103 Utilization review plan](https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-103.md)
- [Mont. Code Ann. § 33-32-104 33-32-104 Preemption by federal law](https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-104.md)
- [Mont. Code Ann. § 33-32-105 33-32-105 Application -- exemptions](https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-105.md)
- [Mont. Code Ann. § 33-32-106 33-32-106 Disclosure of utilization review requirements -- drug benefit information](https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-106.md)
- [Mont. Code Ann. § 33-32-107 33-32-107 Length of prior authorization](https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-107.md)
- [Mont. Code Ann. § 33-32-108 33-32-108 Retroactive denials prohibited](https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-108.md)
- [Mont. Code Ann. § 33-32-109 33-32-109 Biologic prescriptions for minors](https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-109.md)

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/statutes/STATE_MT_T33_C32_P1_S33-32-106. Check the current official text before relying on it. Not legal advice.